Late-stage clinical study of DNL343
Latest Information Update: 14 Aug 2022
At a glance
- Drugs DNL 343 (Primary)
- Indications Amyotrophic lateral sclerosis
- Focus Therapeutic Use
Most Recent Events
- 14 Aug 2022 New trial record
- 08 Aug 2022 According to a Denali Therapeutics Inc media release, based on Phase 1 data and ongoing blinded Phase 1b data, the company has initiated planning for this trial.